Irritable Bowel Syndrome Clinical Trials
Here are the 6 most popular medical studies for irritable bowel syndrome
Antibiotic
Rifaximin + Low FODMAP Diet for Irritable Bowel Syndrome
This trial will compare the effectiveness of two treatments for diarrhea-predominant irritable bowel syndrome (IBS-D). Half of the patients will receive the antibiotic rifaximin, while the other half will follow a low FODMAP diet.
Psychedelic Therapy
TRP-8802 for Irritable Bowel Syndrome
This trial is recruiting participants with irritable bowel syndrome (IBS) to study the effects of a drug called TRP-8802. The study will involve two experimental sessions where participants will take an
Behavioural Intervention
Oral Glutamine for Gulf War Syndrome
This trial will provide a novel treatment for veterans with Gulf War Illness who have chronic GI symptoms, which currently have no specific treatments. It could drastically improve the health of many veterans and reduce negative economic effects.
Microbiota Restoration
Fecal Microbiota Transplant for Irritable Bowel Syndrome
This trial studies the safety and effectiveness of FMT using donor stool with low protein breakdown and Alistipes putredinis bacteria to treat PI-IBS and high protein breakdown.
Behavioral Intervention
GUT LINK SmartPath for Gastrointestinal Disorder
This trial aims to evaluate a new method called Clinical Care Pathway for diagnosing and treating lower gastrointestinal tract symptoms, like those seen in IBS. Primary healthcare providers often find it difficult to distinguish between
Popular filter options for irritable bowel syndrome trials
IBS Clinical Trials
View 52 IBS medical studies.
Behavioral Intervention
Digital Self-Help App for Irritable Bowel Syndrome
This trial will test a new digital app version of a self-help intervention for Irritable Bowel Syndrome (IBS) to see if it is an acceptable and effective treatment for improving the overall quality of life in patients with IBS.
Phase 3 Irritable Bowel Syndrome Clinical Trials
View 52 phase 3 irritable bowel syndrome medical studies.
Behavioural Intervention
Fecal Microbiota Transplantation for Depression
This trial is testing whether a treatment called Fecal Microbiota Transplantation (FMT) is effective, safe, and tolerable for adults with Major Depressive Disorder (MDD) who also have Inflammatory Bowel Syndrome (IBS). The study will also look at whether FMT affects cognitive and neural changes associated with MDD and MDD+IBS.
Guanylate Cyclase-C Agonist
Long-Term Safety of Linaclotide for Constipation
This trial will enroll children who have completed other trials testing the drug linaclotide for constipation or irritable bowel syndrome with constipation. The children will take the drug for 24 or 52 weeks depending on the condition.
Irritable Bowel Syndrome Clinical Trials With No Placebo
View 52 irritable bowel syndrome medical studies that do not have a placebo group.
Behavioral Intervention
Digital Self-Help App for Irritable Bowel Syndrome
This trial will test a new digital app version of a self-help intervention for Irritable Bowel Syndrome (IBS) to see if it is an acceptable and effective treatment for improving the overall quality of life in patients with IBS.
View More Irritable Bowel Syndrome Trials
See another 31 medical studies focused on irritable bowel syndrome.
Frequently Asked Questions
Introduction to irritable bowel syndrome
What are the top hospitals conducting irritable bowel syndrome research?
Seeking relief from the often-debilitating symptoms of irritable bowel syndrome (IBS) can be a challenging journey, but thanks to leading hospitals and research centers, progress is being made. In Ann Arbor, Michigan, the University of Michigan takes center stage in pioneering IBS clinical trials with six active studies dedicated to this complex condition. Since conducting their first trial in 2007, they have accumulated an impressive total of 13 investigations aimed at unraveling the mysteries surrounding IBS.
In sunny Miami at the Valencia Medical and Research Center, researchers are also committed to advancing our understanding of IBS. Though relatively new to the field compared to others on this list, they have already recorded three current trials and are building upon their initial foray into IBS research in 2017.
Heading westward to San Antonio's Sun Research Institute reveals another hub for groundbreaking studies related to IBS. With three ongoing trials and a respectable history of eight completed studies since initiating their very first trial back in 2006; it showcases that age-old saying "everything is bigger in Texas," extends even towards advancements in medical science.
Meanwhile, nestled within Los Angeles' prestigious UCLA lies a focus on two current clinical trials targeting IBS symptoms. Although they may seem modest in number compared to other institutions listed here; each undertaking contributes significantly towards expanding our knowledge on how best address these challenges faced by those living with this chronic condition since beginning later just recently alongside its counterpart during2017.
As we venture north across the border into Toronto's Canadian Phase Onward Inc., we encounter yet another institution dedicated not only improving patient outcomes but discovering innovative treatment options as well.With two active trials alongside four previous experiments exploring various facets affecting individuals grappling withIrritable Bowel Syndrome(I.B.S), together accumulating invaluable insights throughout all-time records tracing back till early2005
From coast-to-coast and beyond borders these top hospitals strive relentlessly identifying better ways manage IBS symptoms while delving into the underlying mechanisms of this condition. Through their relentless pursuit in clinical trials, they offer hope to those seeking relief and contribute to a future where living with IBS becomes more manageable for individuals worldwide.
Which are the best cities for irritable bowel syndrome clinical trials?
For irritable bowel syndrome clinical trials, several cities emerge as top contenders for research opportunities. Miami, Florida takes the lead with 21 active trials investigating treatments such as Eluxadoline and Linaclotide at varying dosages. Following closely behind is Houston, Texas with 11 ongoing studies focusing on interventions like 72 μg linaclotide and Eluxadoline. Atlanta, Georgia also shows promise in IBS research with 10 active trials examining similar treatment options. Ann Arbor, Michigan contributes to the field through eight ongoing trials studying interventions such as Rifaximin and specialized diets. Lastly, Stockbridge, Georgia offers seven active trials exploring potential treatments including Eluxadoline and Linaclotide across different dosages. These cities present individuals dealing with irritable bowel syndrome an opportunity to participate in cutting-edge clinical research that may pave the way for improved care outcomes in this condition.
Which are the top treatments for irritable bowel syndrome being explored in clinical trials?
Exciting developments are underway in the world of irritable bowel syndrome (IBS) treatments, with several options showing promise in clinical trials. Leading the way is rifaximin, currently being explored in two active trials dedicated to IBS. This powerful drug first entered the scene in 2007 and has since accumulated a total of 12 all-time clinical trials focused on this condition. Additionally, two different diets have emerged as potential therapies for IBS: Diet A and a diet low in all FODMAP groups. Both diets are each being investigated through one active trial, which marks their initial foray into research specifically targeting IBS. As these trials progress and results come to light, new avenues of relief may soon be available to individuals living with this challenging disorder.
What are the most recent clinical trials for irritable bowel syndrome?
Exciting advancements are being made in the field of irritable bowel syndrome (IBS) research, with recent clinical trials offering promising possibilities for improved treatment options. One notable trial involves the use of donor fecal microbiota transplantation (FMT) as a potential therapy for IBS. This Phase 2 study aims to investigate the effectiveness and safety of FMT in alleviating symptoms associated with this condition. Another noteworthy trial focuses on tenapanor, which is currently undergoing Phase 3 testing for its efficacy in managing IBS symptoms. Additionally, a Phase 3 trial exploring the effects of tenapanor at a specific dosage has also become available recently. With these compelling studies underway, there is renewed hope for individuals suffering from IBS to find relief and enhance their quality of life.
What irritable bowel syndrome clinical trials were recently completed?
Recently, three important clinical trials focusing on irritable bowel syndrome (IBS) have concluded, enhancing our understanding and treatment options for this complex condition. In December 2021, Michael Camilleri, MD completed a trial investigating the efficacy of Aldafermin. Cedars-Sinai Medical Center also wrapped up their own study in November 2020 on Rifaximin's potential benefits. Additionally, Beth Israel Deaconess Medical Center successfully concluded their DS-01 trial in October 2020. These significant advancements shed light on innovative approaches to managing IBS symptoms and offer hope for individuals grappling with this challenging gastrointestinal disorder.